深圳信立泰药业股份有限公司关于控股股东部分股份解除质押的公告

Group 1 - The company received notification from its controlling shareholder, Hong Kong Xinlitai Pharmaceutical Co., Ltd., regarding the release of part of its pledged shares [1][2] - As of the announcement date, the controlling shareholder holds 635.27938 million shares, accounting for 56.99% of the company's total shares [3] - After the release of the pledged shares, the total number of shares under pledge is 97 million, which represents 15.27% of the controlling shareholder's total holdings and 8.70% of the company's total shares [3][4] Group 2 - There are no frozen, marked, auctioned, or trust-set shares held by the controlling shareholder [2][4] - The controlling shareholder has a good credit status and repayment capability, indicating that the risk associated with pledged shares is manageable [4] - The pledge of shares will not lead to a change in the actual control of the company and will not affect its operations or governance [4]